ArticleBMJ case reports2022

Partial response to dabrafenib and trametinib in relapsed BRAF V600E-Mutated multiple myeloma and possible mechanisms of resistance.

Tina Ernst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.